Ophthalmology Innovation Source

Our CEO Paul Bresge will be moderating a panel at Ophthalmology Innovation Source Summit 2024 on November 22, 4.05-4.40 pm PT. 🧬🧬 Investor Strategy: Understanding Your Investors And Your Investment Strategies Panelists: Anna H. Chen, PhD, Principal - Frazier Life Sciences Jeffrey Friedman, MD, PhD, Managing Partner - Friedman BioVenture Joe Markson, PhD, Principal - Novo Holdings Zach Scheiner, PhD, Principal - RA Capital Management Co-Moderated By: Paul Bresge, CEO - Ray Therapeutics, Inc. Jason Jun, Managing Director, Healthcare Investment Banking - Citi Our Chief Medical & Scientific Officer Peter Francis, MD PhD will be giving a company presentation in the Cell & Gene Therapy Showcase at 4.40-5.30 pm ET. More info here: 👇👇 https://lnkd.in/eSUHtXDp

𝗢𝗜𝗦 𝗫𝗜𝗩 𝗵𝗮𝘀 𝗼𝗳𝗳𝗶𝗰𝗶𝗮𝗹𝗹𝘆 𝘀𝗼𝗹𝗱 𝗼𝘂𝘁! Join our waitlist today for a chance to grab an open spot. Act fast—availability is limited and offered on a first-come, first-serve basis! https://lnkd.in/gd2zEj2g #OIS #OISXIV #Ophthalmology #Innovation #Waitlist

𝘈 𝘚𝘱𝘦𝘤𝘪𝘢𝘭 𝘔𝘦𝘴𝘴𝘢𝘨𝘦 𝘧𝘳𝘰𝘮 𝘰𝘶𝘳 𝘔𝘢𝘯𝘢𝘨𝘪𝘯𝘨 𝘋𝘪𝘳𝘦𝘤𝘵𝘰𝘳: "I'm excited to welcome you all to OIS XIV this Friday, November 22nd, at the Hard Rock Hotel San Diego. Looking forward to bringing the OIS Community together to close out the year with innovation and connection!" https://ois.net/ois-xiv/ #OIS #OISXIV #Ophthalmology #Innovation #OpeningRemarks

We’re excited to introduce our 𝟰 𝗶𝗻𝗰𝗿𝗲𝗱𝗶𝗯𝗹𝗲 𝗼𝗻𝘀𝗶𝘁𝗲 𝗶𝗻𝘁𝗲𝗿𝘃𝗶𝗲𝘄 𝗵𝗼𝘀𝘁𝘀! They'll be covering the hottest topics and chatting with industry leaders. Don’t miss their exclusive interviews—happening live at 𝗢𝗜𝗦 𝗫𝗜𝗩! https://ois.net/ois-xiv/ #OIS #OISXIV #Ophthalmology #Innovation #OnsiteInterview

𝗛𝗮𝗽𝗽𝘆 𝗢𝗜𝗦 𝗫𝗜𝗩 𝗪𝗲𝗲𝗸! The countdown is on for 2 incredible days of innovation, insights, and networking—kicking off this Friday! We can’t wait to see you there. Let’s make it unforgettable! https://ois.net/ois-xiv/ #OIS #OISXIV #Ophthalmology #Innovation

𝐎𝐈𝐒 𝐗𝐈𝐕 kicks off 𝘵𝘩𝘪𝘴 𝘸𝘦𝘦𝘬 at the Hard Rock Hotel San Diego! With incredible demand, 𝐬𝐩𝐨𝐭𝐬 𝐚𝐫𝐞 𝐟𝐢𝐥𝐥𝐢𝐧𝐠 𝐟𝐚𝐬𝐭—𝐰𝐞'𝐫𝐞 𝐧𝐞𝐚𝐫𝐢𝐧𝐠 𝐦𝐚𝐱 𝐜𝐚𝐩𝐚𝐜𝐢𝐭𝐲! Don’t miss 2 packed days with 200+ top ophthalmic companies, 100+ speakers, and unmatched networking opportunities. Check the agenda & register now before it’s too late! https://lnkd.in/eSUHtXDp #OIS #Innovation #OISInnovation #OISXIV #Ophthalmology #OphthalmologyInnovation #Agenda #LimitedSeats

Opthea 𝘄𝗲𝗹𝗰𝗼𝗺𝗲𝘀 𝗞𝗮𝘁𝗵𝘆 𝗖𝗼𝗻𝗻𝗲𝗹𝗹 𝘁𝗼 𝗶𝘁𝘀 𝗕𝗼𝗮𝗿𝗱 𝗼𝗳 𝗗𝗶𝗿𝗲𝗰𝘁𝗼𝗿𝘀, 𝗯𝗿𝗶𝗻𝗴𝗶𝗻𝗴 𝗱𝗲𝗲𝗽 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗲𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲 𝗮𝘀 𝘁𝗵𝗲 𝗰𝗼𝗺𝗽𝗮𝗻𝘆 𝗽𝗿𝗲𝗽𝗮𝗿𝗲𝘀 𝗳𝗼𝗿 𝗽𝗶𝘃𝗼𝘁𝗮𝗹 𝗣𝗵𝗮𝘀𝗲 𝟯 𝘄𝗲𝘁 𝗔𝗠𝗗 𝗱𝗮𝘁𝗮 𝗶𝗻 𝟮𝟬𝟮𝟱. #Opthea #RetinalInnovation #Leadership https://lnkd.in/gmZQpZub

Join us at 𝗢𝗜𝗦 𝗫𝗜𝗩 to hear from Adam G. of AesculaTech on 𝗛𝘂𝗺𝗶𝗱𝗶𝗳𝗲𝘆𝗲—a new dry eye treatment using smart hydrogel technology and the smallest prefilled autoinjector! Learn how AesculaTech is advancing personalized care in ophthalmology. https://lnkd.in/eMd2jAJc #OIS #OISXIV #Ophthalmology #Innovation #AesculaTech #AdamGriese

A big thank you to Opthea for sponsoring 𝗢𝗜𝗦 𝗫𝗜𝗩! Opthea’s innovative work, especially with their lead candidate sozinibercept in Phase 3 trials, brings new hope to patients with retinal diseases like wet AMD and DME. Make sure to register and catch their presentation onsite—and connect with the Opthea team in San Diego! https://lnkd.in/eMd2jAJc #OIS #OISXIV #Ophthalmology #Innovation #Opthea

𝗢𝗻𝗹𝘆 𝟮 𝘄𝗲𝗲𝗸𝘀 𝗹𝗲𝗳𝘁 𝘂𝗻𝘁𝗶𝗹 𝗢𝗜𝗦 𝗫𝗜𝗩! Start your day with the Morning Startup Bootcamp on Friday, Nov 22, at 9 AM—open to all registrants. This bonus session delivers essential insights for early-stage ophthalmology companies, guiding them from preclinical phases to successful commercialization. Don’t miss out on valuable takeaways for founders and execs alike—register today! https://lnkd.in/eMd2jAJc #OIS #OISXIV #Ophthalmology #Innovation #OISBootcamp #StartupBootcamp